The clinical value of fibrosis indices for predicting the hemorrhagic transformation in patients with acute ischemic stroke after intravenous thrombolysis

被引:1
作者
Chen, Jiahao [1 ]
Li, Xiaoqin [1 ]
Hu, Rui [2 ]
Hu, Chuanchen [1 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Neurol, Sch Med, Jinhua, Peoples R China
[2] Yongkang First Peoples Hosp, Dept Neurol, Jinhua, Peoples R China
关键词
acute ischemic stroke; hemorrhagic transformation; intravenous thrombolysis; non-alcoholic fatty liver disease; liver fibrosis; TISSUE-PLASMINOGEN-ACTIVATOR; SIMPLE NONINVASIVE INDEX; FATTY LIVER-DISEASE; OUTCOMES; RISK; ASSOCIATION; MORTALITY; CIRRHOSIS;
D O I
10.3389/fnagi.2024.1492410
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background The incidence of stroke in China is approximately 343 per 100,000 people each year, the highest rate worldwide. Hemorrhagic transformation (HT), particularly symptomatic intracerebral hemorrhage (sICH) following acute ischemic stroke (AIS) with or without intravenous thrombolysis (IVT), can lead to rapid neurological deterioration, poor prognosis, and even death. Non-alcoholic fatty liver disease (NAFLD) has been identified as a risk factor for stroke occurrence and associated with poor long-term functional outcomes. Nonetheless, no studies have examined the association between liver fibrosis and HT in AIS patients who underwent IVT. Method A total of 826 patients with AIS who underwent IVT were included in this study. We calculated nine validated liver fibrosis indices to assess the extent of liver fibrosis. HT was detected by follow-up cranial CT/MRI within 24 h post-IVT and was classified as either hemorrhagic infarction (HI) or parenchymal hematoma (PH). Symptomatic intracranial hemorrhage was defined as a sudden symptomatic neurological deterioration, indicated by an increase in (National Institutes of Health Stroke Scale) NIHSS score of 4 points or more. Result The median values of fibrosis-4 (FIB-4), modified FIB-4 (mFIB-4), aspartate aminotransferase (AST)-platelet ratio index (APRI), Forns index, alanine aminotransferase (ALT)/AST (ARR), AST/ALT ratio-platelet ratio index (AARPRI), fibrosis quotient (FibroQ), and Fibrosis Index were significantly higher, while the fibrosis-5 (FIB-5) was significantly lower in the HT and sICH groups (all P < 0.001). After adjusting for potential confounders, all nine liver fibrosis indices remained associated with HT and sICH. Receiver operating characteristic (ROC) curve analysis revealed that the FibroQ score had the best predictive ability for HT (AUC = 0.707, CI = 0.652-0.762, P < 0.001), while FIB-4 had the best predictive ability for sICH (AUC = 0.802, CI = 0.711-0.892, P < 0.001). Conclusion Liver fibrosis, as validated by FIB-4, mFIB-4, FIB-5, APRI, Forns index, ARR, AARPRI, FibroQ, and Fibrosis Index, was associated with HT and sICH in AIS patients after IVT.
引用
收藏
页数:13
相关论文
共 43 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases [J].
Assy, N. ;
Bekirov, I. ;
Mejritsky, Y. ;
Solomon, L. ;
Szvalb, S. ;
Hussein, O. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (37) :5834-5839
[3]   A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C [J].
Attallah, AM ;
Shiha, GE ;
Omran, MM ;
Zalata, KR .
HEPATOLOGY RESEARCH, 2006, 34 (03) :163-169
[4]   Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients [J].
Baik, Minyoul ;
Kim, Seung Up ;
Kang, Sungwoo ;
Park, Hyung Jong ;
Nam, Hyo Suk ;
Heo, Ji Hoe ;
Kim, Beom Kyung ;
Park, Jun Yong ;
Kim, Do Young ;
Ahn, Sang Hoon ;
Han, Kwang-Hyub ;
Lee, Hye Sun ;
Kim, Young Dae .
CEREBROVASCULAR DISEASES, 2019, 47 (1-2) :32-39
[5]   Non-invasive assessment of steatohepatitis indicates increased risk of coronary artery disease [J].
Beer, Sebastian ;
Babel, Jonas ;
Martin, Neef ;
Blank, Valentin ;
Wiegand, Johannes ;
Karlas, Thomas .
PLOS ONE, 2023, 18 (09)
[6]   MEASUREMENTS OF ACUTE CEREBRAL INFARCTION - A CLINICAL EXAMINATION SCALE [J].
BROTT, T ;
ADAMS, HP ;
OLINGER, CP ;
MARLER, JR ;
BARSAN, WG ;
BILLER, J ;
SPILKER, J ;
HOLLERAN, R ;
EBERLE, R ;
HERTZBERG, V ;
RORICK, M ;
MOOMAW, CJ ;
WALKER, M .
STROKE, 1989, 20 (07) :864-870
[7]   AST/ALT-to-platelet ratio (AARPRI) predicts gynaecological cancers: a 8-years follow-up study in 653 women [J].
Crudele, Lucilla ;
De Matteis, Carlo ;
Graziano, Giusi ;
Novielli, Fabio ;
Petruzzelli, Stefano ;
Piccinin, Elena ;
Gadaleta, Raffaella Maria ;
Cariello, Marica ;
Moschetta, Antonio .
SCIENTIFIC REPORTS, 2023, 13 (01)
[8]   Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease [J].
du Plessis, Johannie ;
van Pelt, Jos ;
Korf, Hannelie ;
Mathieu, Chantal ;
van der Schueren, Bart ;
Lannoo, Matthias ;
Oyen, Tom ;
Topal, Baki ;
Fetter, Gary ;
Nayler, Simon ;
van der Merwe, Tessa ;
Windmolders, Petra ;
Van Gaal, Luc ;
Verrijken, An ;
Hubens, Guy ;
Gericke, Martin ;
Cassiman, David ;
Francque, Sven ;
Nevens, Frederik ;
van der Merwe, Schalk .
GASTROENTEROLOGY, 2015, 149 (03) :635-+
[9]  
EASL, 2016, OBESITY FACTS, V9, P65, DOI [10.1159/000443344, 10.1007/s00125-016-3902-y, 10.1016/j.jhep.2015.11.004]
[10]   Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up [J].
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Fredrikson, Mats ;
Stal, Per ;
Kechagias, Stergios ;
Hultcrantz, Rolf .
HEPATOLOGY, 2015, 61 (05) :1547-1554